Skip to main content
. 2022 Jul;16(2):41–45. doi: 10.5704/MOJ.2207.005

Table III:

Planned/Completed Management of patients presenting to PJI MTD meeting

Planned/Completed Management n (%)
Debridement-Antibiotic-Implant Retention 22 (21.8%)
One stage revision arthroplasty 4 (4.0%)
Two stage revision arthroplasty 28 (27.8%)
Primary joint arthroplasty 9 (8.9%)
Ongoing Clinical Review 24 (23.8%)
Antibiotic suppression 14 (13.9%)